Bozepinib, a novel small antitumor agent, induces PKR-mediated apoptosis and synergizes with IFNα triggering apoptosis, autophagy and senescence

References

• Ferlay J Shin HR Bray F Forman D Mathers C Parkin DM Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int J Cancer 2010 127 12 2893 2917 21351269
   PubMed Web of Science ®Google Scholar
• Díaz-Gavilán M Conejo-García A Cruz-López O Synthesis and anticancer activity of (R,S)-9-(2,3-dihydro-1,4-benzoxathiin-3-ylmethyl)-9H-purines ChemMedChem 2008 3 1 127 135 18022976
   PubMed Web of Science ®Google Scholar
• Díaz-Gavilán M Gómez-Vidal JA Entrena A Gallo MA Espinosa A Campos JM Study of the factors that control the ratio of the products between 5-fluorouracil, uracil, and tetrahydrobenzoxazepine O,O-acetals bearing electron-withdrawing groups on the nitrogen atom J Org Chem 2006 71 3 1043 1054 16438519
   PubMed Web of Science ®Google Scholar
• Núñez MC Díaz-Gavilán M Conejo-García A Design, synthesis and anticancer activity against the MCF-7 cell line of benzo-fused 1,4-dihetero seven- and six-membered tethered pyrimidines and purines Curr Med Chem 2008 15 25 2614 2631 18855682
   PubMed Web of Science ®Google Scholar
• López-Cara LC Conejo-García A Marchal JA New (RS)-benzoxazepin-purines with antitumour activity: the chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine Eur J Med Chem 2011 46 1 249 258 21126804
   PubMed Web of Science ®Google Scholar
• Ferri KF Kroemer G Organelle-specific initiation of cell death pathways Nat Cell Biol 2001 3 11 E255 E263 11715037
   PubMed Web of Science ®Google Scholar
• de Bruin EC Medema JP Apoptosis and non-apoptotic deaths in cancer development and treatment response Cancer Treat Rev 2008 34 8 737 749 18722718
   PubMed Web of Science ®Google Scholar
• Mansilla S Llovera L Portugal J Chemotherapeutic targeting of cell death pathways Anticancer Agents Med Chem 2012 12 3 226 238 22263795
   PubMed Web of Science ®Google Scholar
• White E Karp C Strohecker AM Guo Y Mathew R Role of autophagy in suppression of inflammation and cancer Curr Opin Cell Biol 2010 22 2 212 217 20056400
   PubMed Web of Science ®Google Scholar
• Dalby KN Tekedereli I Lopez-Berestein G Ozpolat B Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer Autophagy 2010 6 3 322 329 20224296
   PubMed Web of Science ®Google Scholar
• Hayflick L Moorhead PS The serial cultivation of human diploid cell strains Exp Cell Res 1961 25 3 585 621 13905658
   PubMed Web of Science ®Google Scholar
• Kong Y Cui H Ramkumar C Zhang H Regulation of senescence in cancer and aging J Aging Res 2011 2011 963172 21423549
   PubMedGoogle Scholar
• Hasselbalch HC Interferon alpha2 in the treatment of hematological malignancies. Status and perspectives Curr Drug Targets 2011 12 3 387 391 21143152
   PubMed Web of Science ®Google Scholar
• Tarhini AA Gogas H Kirkwood JM IFN-alpha in the treatment of melanoma J Immunol 2012 189 8 3789 3793 23042723
   PubMed Web of Science ®Google Scholar
• Kirkwood J Cancer immunotherapy: the interferon-alpha experience Semin Oncol 2002 29 3 Suppl 7 18 26 12068384
   PubMed Web of Science ®Google Scholar
• Dal Col J Mastorci K Fae DA Retinoic acid/alpha-interferon combination inhibits growth and promotes apoptosis in mantle cell lymphoma through Akt-dependent modulation of critical targets Cancer Res 2012 72 7 1825 1835 22311672
   PubMed Web of Science ®Google Scholar
• Tarhini AA Cherian J Moschos SJ Safety and efficacy of c ombination immunotherapy with interferon alfa-2b and tremelimumab in patients with stage IV melanoma J Clin Oncol 2012 30 3 322 328 22184371
   PubMed Web of Science ®Google Scholar
• Simonsson B Hjorth-Hansen H Bjerrum OW Porkka K Interferon alpha for treatment of chronic myeloid leukemia Curr Drug Targets 2011 12 3 420 428 21143150
   PubMed Web of Science ®Google Scholar
• Negrier S Gravis G Perol D Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial Lancet Oncol 2011 12 7 673 680 21664867
   PubMed Web of Science ®Google Scholar
• Esteban M Kerr IM The synthesis of encephalomyocarditis virus polypeptides in infected L-cells and cell-free systems Eur J Biochem 1974 45 2 567 576 4369366
   PubMedGoogle Scholar
• García MA Gil J Ventoso I Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action Microbiol Mol Biol Rev 2006 70 4 1032 1060 17158706
   PubMed Web of Science ®Google Scholar
• Yoon CH Lee ES Lim DS Bae YS PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53 Proc Natl Acad Sci U S A 2009 106 19 7852 7857 19416861
   PubMed Web of Science ®Google Scholar
• Peidis P Papadakis AI Muaddi H Richard S Koromilas AE Doxorubicin bypasses the cytoprotective effects of eIF2alpha phosphorylation and promotes PKR-mediated cell death Cell Death Differ 2011 18 1 145 154 20559319
   PubMed Web of Science ®Google Scholar
• García MA Carrasco E Aguilera M The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner in colon and breast cancer cells PLoS One 2011 6 8 e23887 21887339
   PubMed Web of Science ®Google Scholar
• Yang YL Reis LF Pavlovic J Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase EMBO J 1995 14 24 6095 6106 8557029
   PubMed Web of Science ®Google Scholar
• Bunz F Hwang PM Torrance C Disruption of p53 in human cancer cells alters the responses to therapeutic agents J Clin Invest 1999 104 3 263 269 10430607
   PubMed Web of Science ®Google Scholar
• Villalobos C García-Sancho J Capacitative Ca2+ entry contributes to the Ca2+ influx induced by thyrotropin-releasing hormone (TRH) in GH3 pituitary cells Pflugers Arch 1995 430 6 923 935 8594545
   PubMed Web of Science ®Google Scholar
• Yang XH Sladek TL Liu X Butler BR Froelich CJ Thor AD Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis Cancer Res 2001 61 1 348 354 11196185
   PubMed Web of Science ®Google Scholar
• Yoon YH Cho KS Hwang JJ Lee SJ Choi JA Koh JY Induction of lysosomal dilatation, arrested autophagy, and cell death by chloroquine in cultured ARPE-19 cells Invest Ophthalmol Vis Sci 2010 51 11 6030 6037 20574031
   PubMed Web of Science ®Google Scholar
• Geng Y Kohli L Klocke BJ Roth KA Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent Neuro Oncol 2010 12 5 473 481 20406898
   PubMed Web of Science ®Google Scholar
• Holcik M Sonenberg N Translational control in stress and apoptosis Nat Rev Mol Cell Biol 2005 6 4 318 327 15803138
   PubMed Web of Science ®Google Scholar
• Martínez-Rivera M Siddik ZH Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53 Biochem Pharmacol 2012 83 8 1049 1062 22227014
   PubMed Web of Science ®Google Scholar
• Konstantakou EG Voutsinas GE Karkoulis PK Aravantinos G Margaritis LH Stravopodis DJ Human bladder cancer cells undergo cisplatin-induced apoptosis that is associated with p53-dependent and p53-independent responses Int J Oncol 2009 35 2 401 416 19578756
   PubMed Web of Science ®Google Scholar
• Backus HH Wouters D Ferreira CG Thymidylate synthase inhibition triggers apoptosis via caspases-8 and -9 in both wild-type and mutant p53 colon cancer cell lines Eur J Cancer 2003 39 9 1310 1317 12763222
   PubMed Web of Science ®Google Scholar
• Nakamura M Nagano H Sakon M Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro J Hepatol 2007 46 1 77 88 17045692
   PubMed Web of Science ®Google Scholar
• Philchenkov A Zavelevich M Kroczak TJ Los M Caspases and cancer: mechanisms of inactivation and new treatment modalities Exp Oncol 2004 26 2 82 97 15273659
   PubMed Web of Science ®Google Scholar
• Janicke RU Ng P Sprengart ML Porter AG Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis J Biol Chem 1998 273 25 15540 15545 9624143
   PubMed Web of Science ®Google Scholar
• Akar U Chaves-Reyez A Barria M Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells Autophagy 2008 4 5 669 679 18424910
   PubMed Web of Science ®Google Scholar
• Xue L Fletcher GC Tolkovsky AM Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution Mol Cell Neurosci 1999 14 3 180 198 10576889
   PubMed Web of Science ®Google Scholar
• Lee HK Lund JM Ramanathan B Mizushima N Iwasaki A Autophagy-dependent viral recognition by plasmacytoid dendritic cells Science 2007 315 5817 1398 1401 17272685
   PubMed Web of Science ®Google Scholar
• Desai MM Gong B Chan T Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver Gastroenterology 2011 141 2 674 685 21683701
   PubMed Web of Science ®Google Scholar
• Akiyama M Iwase S Horiguchi-Yamada J Interferon-alpha repressed telomerase along with G1-accumulation of Daudi cells Cancer Lett 1999 142 1 23 30 10424777
   PubMed Web of Science ®Google Scholar
• Li Q Tang L Roberts PC Interferon regulatory factors IRF5 and IRF7 inhibit growth and induce senescence in immortal Li-Fraumeni fibroblasts Mol Cancer Res 2008 6 5 770 784 18505922
   PubMed Web of Science ®Google Scholar
• Upreti M Koonce NA Hennings L Chambers TC Griffin RJ Pegylated IFN-alpha sensitizes melanoma cells to chemotherapy and causes premature senescence in endothelial cells by IRF-1 mediated signaling Cell Death Dis 2010 1 e67 21197417
   PubMed Web of Science ®Google Scholar